Characteristics of community-acquired carbapenem-resistant Enterobacterales

被引:12
|
作者
Shrestha, Rima [1 ]
Luterbach, Courtney L. [1 ,2 ]
Dai, Weixiao [3 ]
Komarow, Lauren [3 ]
Earley, Michelle [3 ]
Weston, Gregory [4 ]
Herc, Erica [5 ]
Jacob, Jesse T. [6 ,7 ]
Salata, Robert [8 ]
Wong, Darren [9 ]
Anderson, Deverick [10 ,11 ]
Rydell, Kirsten B. [12 ]
Arias, Cesar A. [12 ,13 ,14 ]
Chen, Liang [15 ,16 ]
van Duin, David [1 ]
机构
[1] Univ N Carolina, Div Infect Dis, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC 27515 USA
[3] George Washington Univ, Biostat Ctr, Rockville, MD USA
[4] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med, Div Infect Dis, Bronx, NY 10467 USA
[5] Henry Ford Hosp, Dept Med, Div Infect Dis, Detroit, MI 48202 USA
[6] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA
[7] Emory Antibiot Resistance Ctr, Atlanta, GA USA
[8] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA
[9] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
[10] Duke Univ, Sch Med, Div Infect Dis, Durham, NC USA
[11] Duke Ctr Antimicrobial Stewardship & Infect Preve, Durham, NC USA
[12] Houston Methodist Hosp, Div Infect Dis, Houston, TX 77030 USA
[13] Houston Methodist Res Inst, Ctr Infect Dis Res, Houston, TX USA
[14] Weill Cornell Med Coll, Houston, TX USA
[15] Hackensack Meridian Hlth, Ctr Discovery & Innovat, Nutley, NJ USA
[16] Hackensack Meridian Sch Med, Dept Med Sci, Nutley, NJ USA
基金
美国国家卫生研究院;
关键词
SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; TYPE-1; FIMBRIAE; PHASE VARIATION; INFECTION; EPIDEMIOLOGY; SURVEILLANCE;
D O I
10.1093/jac/dkac239
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Community-acquired carbapenem-resistant Enterobacterales (CA-CRE) are an important threat. Methods In CRACKLE-2, we defined patients with CA-CRE as admitted from home, without pre-existing conditions, and a positive culture within 48 h of admission. Healthcare-associated CRE (HA-CRE) were those with the lowest likelihood of community acquisition, not admitted from home and cultured >48 h after admission. Specific genetic markers in carbapenemase-producing Klebsiella pneumoniae were evaluated through random forest modelling. Results CA-CRE and HA-CRE were detected in 83 (10%) and 208 (26%) of 807 patients. No significant differences were observed in bacterial species or strain type distribution. K. pneumoniae (204/291, 70%) was the most common CRE species, of these 184/204 (90%) were carbapenemase producers (CPKP). The top three genetic markers in random forest models were kpi_SA15, fimE, and kpfC. Of these, kpi_SA15 (which encodes a chaperone/usher system) was positively associated (OR 3.14, 95% CI 1.13-8.87, P = 0.026), and kpfC negatively associated (OR 0.21, 95% CI 0.05-0.72, P = 0.015) with CA-CPKP. Conclusions Ten percent of CDC-defined CRE were CA. The true proportion of CA-CRE in hospitalized patients is likely lower as patients may have had unrecorded prior healthcare exposure. The kpi_SA15 operon was associated with the CA phenotype.
引用
收藏
页码:2763 / 2771
页数:9
相关论文
共 50 条
  • [1] Carbapenem-resistant Enterobacterales in the USA
    Gandra, Sumanth
    Burnham, Carey-Ann D.
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 637 - 639
  • [2] Characteristics of a Carbapenem-Resistant Acinetobacter baumannii Strain Causing Community-Acquired Pneumonia in a Young Healthy Women
    Chen, Yan
    Xu, Liqun
    Wang, Jianfeng
    [J]. INFECTION AND DRUG RESISTANCE, 2023, 16 : 7819 - 7826
  • [3] Monitoring Carbapenem-Resistant Enterobacterales in the Environment to Assess the Spread in the Community
    Urase, Taro
    Goto, Saki
    Sato, Mio
    [J]. ANTIBIOTICS-BASEL, 2022, 11 (07):
  • [4] Clinical characteristics and outcomes of carbapenem-resistant Enterobacterales bacteremia in pediatric patients
    Liu, Yu-Cheng
    Lu, Chun-Yi
    Chang, Luan-Yin
    Chen, Jong -Min
    Lee, Ping-Ing
    Huang, Li -Min
    [J]. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2023, 56 (01) : 84 - 92
  • [5] Clinical characteristics and treatment outcomes of carbapenem-resistant Enterobacterales infections in Japan
    Oka, Keisuke
    Matsumoto, Akane
    Tetsuka, Nobuyuki
    Morioka, Hiroshi
    Iguchi, Mitsutaka
    Ishiguro, Nobuhisa
    Nagamori, Tsunehisa
    Takahashi, Satoshi
    Saito, Norihiro
    Tokuda, Koichi
    Igari, Hidetoshi
    Fujikura, Yuji
    Kato, Hideaki
    Kanai, Shinichiro
    Kusama, Fumiko
    Iwasaki, Hiromichi
    Furuhashi, Kazuki
    Baba, Hisashi
    Nagao, Miki
    Nakanishi, Masaki
    Kasahara, Kei
    Kakeya, Hiroshi
    Chikumi, Hiroki
    Ohge, Hiroki
    Azuma, Momoyo
    Tauchi, Hisamichi
    Shimono, Nobuyuki
    Hamada, Yohei
    Takajo, Ichiro
    Nakata, Hirotomo
    Kawamura, Hideki
    Fujita, Jiro
    Yagi, Tetsuya
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 29 : 247 - 252
  • [6] Carbapenem-resistant Enterobacterales (CRE): The storm is coming
    Zahar, Jean-Ralph
    Blot, Stijn
    [J]. INTENSIVE AND CRITICAL CARE NURSING, 2023, 79
  • [7] Activity of mecillinam against carbapenem-resistant Enterobacterales
    Emeraud, Cecile
    Godmer, Alexandre
    Girlich, Delphine
    Vanparis, Oceane
    Mahamdi, Feriel
    Creton, Elodie
    Jousset, Agnes B.
    Naas, Thierry
    Bonnin, Remy A.
    Dortet, Laurent
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (10) : 2835 - 2839
  • [8] Risk Factors and Outcomes of Community-Acquired Carbapenem-Resistant Klebsiella pneumoniae Infection in Elderly Patients
    Chen, Yen-Chou
    Tsai, I-Ting
    Lai, Chung-Hsu
    Lin, Kuo-Hsuan
    Hsu, Yin-Chou
    [J]. ANTIBIOTICS-BASEL, 2024, 13 (03):
  • [9] Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
    Fadlallah, Mahdi
    Salman, Ahmad
    Salem-Sokhn, Elie
    [J]. INTERNATIONAL JOURNAL OF MICROBIOLOGY, 2023, 2023
  • [10] Guidelines for Antibacterial Treatment of Carbapenem-Resistant Enterobacterales Infections
    Park, Se Yoon
    Baek, Yae Jee
    Kim, Jung Ho
    Seong, Hye
    Kim, Bongyoung
    Kim, Yong Chan
    Yoon, Jin Gu
    Heo, Namwoo
    Moon, Song Mi
    Kim, Young Ah
    Song, Joon Young
    Choi, Jun Yong
    Park, Yoon Soo
    [J]. INFECTION AND CHEMOTHERAPY, 2024, 56 (03): : 308 - 328